No experience
Employment Type:
Job Category:
Intern - Oncology and Translational Sciences, Summer...
(This job is no longer available)
Regeneron | Basking Ridge, NJ
Grad Date

Not sure what types of jobs you are interested in?

Explore Jobs
Based on Your Education

Follow This Company

Job Description

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases.

This position is in Oncology and Translational Sciences within Global Development in Basking Ridge, New Jersey. The student will be working in the Lung program in the Oncology Clinical Sciences Group within Clinical Research & Development. There will be opportunity to learn clinical trial data review and reconciliation activities, and gain exposure to database lock and submission activities.

Start building your skills at Regeneron.

* Must be a pursuing a Bachelor's or PharmD
* Must be pursuing a degree in Nursing (RN/BSN Majors), or PharmD
* Must be proficient in Microsoft (eg, excel, Word), be able to review, analyze & summarize aspects of clinical trial data, have the ability to work with cross functional teams for data reconciliation
* Must be able to prepare and review study related documents

General Intern Program Information:

* Must be enrolled in, or accepted to, an academic program pursuing a Bachelor's, Master's, PhD or PharmD
* Summer Program is full-time (~40 hrs/wk) for at least 10 weeks and is paid
* Prefer demonstrated leadership in areas such as campus activities, clubs, sports or the community
* Minimum GPA of 3.0
* You will work with a specific manager on a project(s)
* Enjoy weekly 1 hour Intern Program events: learn about other areas of the company from VPs and other employees, soft skills workshops, networking, volunteering, and more!
* Present to your team on your summer project

Transportation and Housing:

* Housing stipend available for those students who meet mileage requirements
* Get to know other incoming Interns on our closed LinkedIn page when you accept an offer

This is an opportunity to join our select team that is already leading the way in the Pharmaceutical/Biotech industry. Apply today and learn more about Regeneron's unwavering commitment to combining good science & good business.

To all agencies: Please, no phone calls or emails to any employee of Regeneron about this opening. All resumes submitted by search firms/employment agencies to any employee at Regeneron via-email, the internet or in any form and/or method will be deemed the sole property of Regeneron, unless such search firms/employment agencies were engaged by Regeneron for this position and a valid agreement with Regeneron is in place. In the event a candidate who was submitted outside of the Regeneron agency engagement process is hired, no fee or payment of any kind will be paid.

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.

About Regeneron

Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for the treatment of serious medical conditions. As of December 31, 2008, the Company had one marketed product: ARCALYST (rilonacept) Injection for Subcutaneous Use, which is available for prescription in the United States for the treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold auto-inflammatory syndrome (FCAS) and muckle-wells syndrome (MWS) in adults and children aged 12 and older. Regeneron also has six clinical development programs, including three late-stage clinical programs. Its late-stage programs are aflibercept (VEGF Trap), which is being developed in oncology in collaboration with the sanofi-aventis Group; VEGF Trap-Eye, which is being developed in eye diseases using intraocular delivery in collaboration with Bayer HealthCare LLC, and ARCALYST, which is being developed for the treatment of gout. (Source: 10-K)